IGMS
IGM Biosciences Inc

1,316
Loading...
Loading...
IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. It offers the IgM platform to expand upon the inherent properties of IgM antibodies and to allow for the rapid development of engineered therapeutic antibodies. The firm’s product pipeline includes IGM-2323, which is a CD20 x CD3 bispecific IgM antibody designed to treat patients with B cell Non-Hodgkin's lymphoma and other B cell malignancies, IGM-8444, which is an IgM antibody targeting Death Receptor 5 for the treatment of patients with solid and hematologic malignancies, and IGM-7354, which will target the delivery of IL-15 with the goal of inducing immune cell stimulation and proliferation. The company was founded in 2010 and is headquartered in Mountain View, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
149

Frequently Asked Questions

What is Market Cap of IGM Biosciences Inc?
What is the 52-week high for IGM Biosciences Inc?
What is the 52-week low for IGM Biosciences Inc?
What is IGM Biosciences Inc stock price today?
What was IGM Biosciences Inc stock price yesterday?
What is the PE ratio of IGM Biosciences Inc?
What is the Price-to-Book ratio of IGM Biosciences Inc?
What is the 50-day moving average of IGM Biosciences Inc?
How many employess does IGM Biosciences Inc has?

Latest IGMS News

View

Advertisement. Remove ads.

Advertisement. Remove ads.